{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:53:58Z","timestamp":1761893638278,"version":"3.44.0"},"reference-count":8,"publisher":"MJS Publishing, Medical Journals Sweden AB","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Oncologica"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1080\/028418600750063550","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T12:00:13Z","timestamp":1027684813000},"page":"809-813","source":"Crossref","is-referenced-by-count":12,"title":["Health-related Quality of Life and Patients' Perceptions in Interferon-treated Multiple Myeloma Patients"],"prefix":"10.2340","volume":"39","author":[{"given":"Finn Wisl\u00f8ff, Nina","family":"Gulbrandsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1200\/JCO.1992.10.12.1827","volume":"10","author":"Weeks J","year":"1992","journal-title":"J Clin Oncol"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.1997.03550010061041","volume":"278","author":"Leplege A","year":"1997","journal-title":"JAMA"},{"key":"CIT0003","first-page":"212","volume":"124","author":"The Nordic Myeloma Study Group","year":"1996","journal-title":"Interferon-alfa-2b added to melphalan-prednisone for initial and mainte-nance treatment in multiple myeloma. A randomized, controlled trial. Ann Intern Med"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"Aaronson NK","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/0959-8049(95)00296-0","volume":"31","author":"Kaasa S","year":"1995","journal-title":"Eur J Cancer"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1046\/j.1365-2141.1996.352889.x","volume":"92","author":"Wisloff F","year":"1996","journal-title":"Br J Haematol"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1365-2141.1996.d01-1802.x","volume":"94","author":"Wisloff F","year":"1996","journal-title":"Br J Haematol"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00019053-199712010-00009","volume":"12","author":"Nord E","year":"1997","journal-title":"Pharmacoeconomics"}],"container-title":["Acta Oncologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/028418600750063550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:05:31Z","timestamp":1756404331000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/26361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":8,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2009,7,8]]},"published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1080\/028418600750063550"],"URL":"https:\/\/doi.org\/10.1080\/028418600750063550","relation":{},"ISSN":["0284-186X","1651-226X"],"issn-type":[{"type":"print","value":"0284-186X"},{"type":"electronic","value":"1651-226X"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}